Medicare Fraud Investigation Target Letter: What to Do Next

Key Takeaways

  • A target letter signals that federal prosecutors have gathered substantial evidence pointing to the recipient’s involvement in a criminal Medicare fraud scheme.
  • Speaking with investigators without counsel—even to explain innocence—can permanently damage the defense and often leads to additional charges under 18 U.S.C. § 1001.
  • Immediate preservation of all records and a halt to any billing conduct that could be questioned are critical to avoid obstruction and to shape the pre-indictment narrative.
  • Early intervention by experienced white-collar counsel can influence charging decisions, narrow the scope of the investigation, and in some cases persuade the government to decline prosecution altogether.

What a Medicare Fraud Target Letter Actually Means

A target letter is a formal written notice from a federal prosecutor—typically an Assistant United States Attorney or a Department of Justice trial attorney—that informs the recipient he or she is a “target” of a criminal investigation. In the context of Medicare fraud, the letter usually emerges from a multi-agency probe involving the FBI, the HHS Office of Inspector General, or the DOJ’s Criminal Division, Health Care Fraud Unit. The letter is not a charging document. It does not, by itself, impose any legal restraint. Yet its practical weight is immense. Receiving a Medicare fraud target letter means that a grand jury is likely already hearing evidence and that the government believes a criminal violation has occurred and that the recipient participated in it.

Under DOJ internal guidelines, a target is defined as a person for whom the prosecutor has “substantial evidence linking him or her to the commission of a crime.” That threshold is intentionally lower than the proof-beyond-a-reasonable-doubt standard required for conviction, but it is a sobering marker. The letter will often reference specific statutes under investigation, such as health care fraud under 18 U.S.C. § 1347, conspiracy under 18 U.S.C. § 1349, or the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b. It may also invite the recipient to have counsel contact the prosecutor to discuss the matter—a carefully worded opening that demands a strategic response, not a reactive one.

Immediate Protective Measures After Receiving a Target Letter

The hours and days after the letter arrives are fraught with risk. Every action the recipient takes—or fails to take—can become a thread in the government’s narrative. A deliberate, counsel-driven approach is the only safe path. The following steps should be viewed as urgent, non-negotiable priorities.

The single greatest mistake a target makes is believing he can “clear things up” by talking to agents. Federal investigators are trained to build cases, not to exonerate. Any statement, even a well-intentioned one, becomes a potential brick in a false-statements count under 18 U.S.C. § 1001 if the government later characterizes it as inaccurate.
  • Engage experienced federal criminal defense counsel immediately. Medicare fraud cases are document-intensive, highly technical, and often involve parallel civil False Claims Act litigation. Counsel must understand health care regulations, Medicare billing rules, and the interplay between criminal and civil exposure. The attorney-client relationship begins the moment counsel is retained, and all communications should flow through that attorney.
  • Cease any interview or contact with law enforcement. If agents call or appear unannounced, the recipient should politely but firmly decline to speak and provide counsel’s name and contact information. Even peripheral remarks about office practices can be twisted into proof of fraudulent intent.
  • Preserve all documents, records, and electronic data. A document preservation notice should go out internally, instructing all employees and custodians to retain emails, text messages, billing records, patient files, and financial records. The legal duty to preserve arises once litigation is reasonably anticipated, and a target letter unquestionably triggers that obligation. Spoliation—even accidental—can lead to obstruction charges under 18 U.S.C. § 1512 or an adverse inference instruction at trial.
  • Stop any billing conduct that could be characterized as questionable. Continuing to submit claims that rest on the same coding or documentation practices under investigation can be seized upon as evidence of ongoing criminal intent. A billing pause—implemented in coordination with counsel and a qualified health care compliance attorney—is often prudent.
  • Begin an internal forensic audit under privilege. Defense counsel can retain independent experts to review a sample of claims, medical records, and financial flows. The audit does two things: it uncovers the factual landscape before the government defines it, and it arms counsel with data to push back on loss calculations or to demonstrate good faith. The findings remain protected by attorney-client privilege and the work-product doctrine as long as the investigation is properly structured.

How the Government Builds a Medicare Fraud Case and Proves Intent

To mount an effective defense, a target must understand the architecture of a federal health care fraud prosecution. The primary charging statute, 18 U.S.C. § 1347, makes it a crime to “knowingly and willfully execute… a scheme… to defraud any health care benefit program.” Each element—scheme, knowledge, and willfulness—represents a zone the government must conquer beyond a reasonable doubt. A scheme can be as simple as billing for services not rendered, upcoding evaluation and management services, or billing for medically unnecessary equipment. It also includes paying or receiving kickbacks in violation of 42 U.S.C. § 1320a-7b(b), which the Affordable Care Act clarified can serve as a predicate for an 18 U.S.C. § 1347 charge.

Federal prosecutors prove knowledge and willfulness through circumstantial evidence. They scrutinize emails that show an owner ignoring a compliance officer’s warning, billing records that balloon immediately after a new marketer is hired, or claims data that starkly deviates from peer benchmarks. They also use undercover operations, former employees as cooperating witnesses, and data analytics run by the Medicare Fraud Strike Force. Because health care fraud is a specific-intent crime, the defense can rebut the mental state element by showing a good-faith reliance on legal advice, reasonable interpretation of ambiguous regulations, or honest billing mistakes corrected in ordinary course. However, raising such defenses requires meticulous recordkeeping and often expert testimony on industry standards.

Sentencing exposure is calculated under the U.S. Sentencing Guidelines § 2B1.1, which uses loss amount as the primary driver. In Medicare fraud cases, the “loss” often equals the total amount billed to Medicare, not the profit received. That number can reach seven or eight figures rapidly, yielding guideline ranges that exceed 10 or 15 years. Additionally, a conviction under the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, carries up to 10 years per count and mandatory exclusion from federal health care programs. Money laundering charges under 18 U.S.C. § 1956 can add decades. Understanding this exposure is not an exercise in fear-mongering; it is essential context for weighing every pre-indictment decision.

FAQ: Common Questions About Medicare Fraud Target Letters

Does receiving a target letter mean an indictment is inevitable?

No. While a target letter indicates that the government has substantial evidence, it does not guarantee an indictment. Prosecutors may ultimately determine that the evidence cannot sustain a conviction, that key witnesses lack credibility, or that a compliance-based resolution is more appropriate. Early, strategic engagement—through a proffer session or a detailed white paper submitted by defense counsel—can sometimes convince the government to downgrade the recipient to a subject or witness, or to close the case entirely. However, any communication with prosecutors must be carefully negotiated in writing, with clear ground rules, and never undertaken without full command of the facts.

What is the difference between a target, a subject, and a witness in a Medicare fraud investigation?

Under DOJ policy, a “target” is a person against whom substantial evidence links them to a crime and who is likely to be indicted. A “subject” is someone whose conduct falls within the scope of the investigation but for whom the evidence is not yet substantial enough to designate as a target. A “witness” is a person who may have information relevant to the investigation but is not expected to face charges. The classification can evolve. A target letter candidly communicates the most serious standing, and any person who receives one should assume that prosecutors view them as the focus of the case.

Take Decisive Action Now

Federal healthcare fraud investigations move quickly, and the window to protect legal rights narrows with each passing day. Anyone who has received a Medicare fraud target letter should immediately consult a defense team that combines trial experience with deep knowledge of Medicare regulations and the Federal Criminal Code. Early involvement by skilled counsel can make the difference between a negotiated resolution that preserves a license and livelihood and a catastrophic indictment. To schedule a confidential and privileged consultation, contact professional legal counsel today.